CIK: 0001056807
Total reported value
$3.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics INC | Stock-Other | 14.41% | +0.19% | — | |
| 2 | RVMD | Revolution Medicines INC | Stock-Healthcare | 9.00% | -0.15% | -15.55% | |
| 3 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 8.76% | +0.74% | — | |
| 4 | GPCR | Structure Therapeutics INC | Stock-Other | 8.15% | -2.84% | +8.59% | |
| 5 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 4.46% | -1.94% | — | |
| 6 | MIRM | Mirum Pharmaceuticals INC | Stock-Other | 3.98% | +0.68% | — | |
| 7 | GHRS | GH Research PLC | Stock-Other | 3.77% | +0.10% | — | |
| 8 | XNCR | Xencor INC | Stock-Other | 3.68% | -0.94% | +160.34% | |
| 9 | ZYME | Zymeworks INC | Stock-Other | 3.49% | -0.51% | — | |
| 10 | PVLA | Palvella Therapeutics INC | Stock-Other | 3.10% | +0.72% | -24.30% | |
| 11 | KURA | Kura Oncology INC | Stock-Other | 3.01% | -0.82% | — | |
| 12 | STOK | Stoke Therapeutics INC | Stock-Other | 2.42% | +0.22% | +36.73% | |
| 13 | XOMA | Xoma Royalty Corporation | Stock-Other | 2.32% | +0.27% | — | |
| 14 | ABVX | Abivax Sa-adr | Stock-Other | 2.31% | -2.31% | EXIT | |
| 15 | NKTR | Nektar Therapeutics | Stock-Other | 2.22% | +3.65% | +22.17% | |
| 16 | ACIU | AC Immune SA | Stock-Other | 2.10% | -0.36% | — | |
| 17 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 2.02% | +0.32% | -32.23% | |
| 18 | CGEM | Cullinan Therapeutics INC | Stock-Other | 2.00% | +0.60% | — | |
| 19 | TYRA | Tyra Biosciences INC | Stock-Other | 1.88% | +0.53% | -41.70% | |
| 20 | IRON | Disc Medicine INC | Stock-Other | 1.74% | +0.85% | — | |
| 21 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 1.69% | -0.45% | -5.42% | |
| 22 | IVVD | Invivyd INC | Stock-Other | 1.62% | -0.81% | — | |
| 23 | SEPN | Septerna INC | Stock-Other | 1.61% | -0.57% | -57.15% | |
| 24 | ANNX | Annexon INC | Stock-Other | 1.54% | — | +30.40% | |
| 25 | CMPX | Compass Therapeutics INC | Stock-Other | 1.40% | -0.09% | +63.47% | |
| 26 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 1.17% | -0.32% | — | |
| 27 | ✓ | Crescent Biopharma INC. | Stock-Other | 1.10% | +0.51% | +98.06% | |
| 28 | FHTX | Foghorn Therapeutics INC | Stock-Other | 0.96% | -0.07% | — | |
| 29 | RPTX | Repare Therapeutics INC | Stock-Other | 0.90% | -0.90% | EXIT | |
| 30 | AVTX | Avalo Therapeutics INC | Stock-Other | 0.83% | -0.05% | +0.00% | |
| 31 | PEPG | Pepgen INC | Stock-Other | 0.42% | -0.42% | EXIT | |
| 32 | ELDN | Eledon Pharmaceuticals INC | Stock-Other | 0.32% | +0.30% | — | |
| 33 | XFOR | X4 Pharmaceuticals INC | Stock-Other | 0.30% | -0.01% | — | |
| 34 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.28% | -0.28% | EXIT | |
| 35 | MOLN | Molecular Partners AG -adr | Stock-Other | 0.20% | -0.03% | — | |
| 36 | IMA | Imagenebio INC | Stock-Other | 0.19% | -0.01% | — | |
| 37 | TCRX | Tscan Therapeutics INC | Stock-Other | 0.18% | — | — | |
| 38 | TENX | Tenax Therapeutics INC | Stock-Other | 0.14% | +0.03% | — | |
| 39 | VTLUSD | Immunic INC | Stock-Other | 0.14% | +0.13% | — | |
| 40 | IVA | Inventiva SA - Adr | Stock-Other | 0.11% | +0.01% | — | |
| 41 | ✓ | Engene Holdings INC | Stock-Other | 0.08% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GPCR | Structure Therapeutics INC | +4.5% | +8.59% | Add |
| 2 | MLTX | Moonlake Immunotherapeutics | +3% | — | Unchanged |
| 3 | XNCR | Xencor INC | +2.4% | +160.34% | Add |
| 4 | OLMA | Olema Pharmaceuticals INC | +2.4% | — | Unchanged |
| 5 | KYMR | Kymera Therapeutics INC | +1.8% | — | Unchanged |
| 6 | RVMD | Revolution Medicines INC | +1.5% | -15.55% | Trim |
| 7 | STOK | Stoke Therapeutics INC | +0.8% | +36.73% | Add |
| 8 | ZYME | Zymeworks INC | +0.8% | — | Unchanged |
| 9 | CMPX | Compass Therapeutics INC | +0.7% | +63.47% | Add |
| 10 | ANNX | Annexon INC | +0.7% | +30.40% | Add |
| 11 | CGEM | Cullinan Therapeutics INC | +0.6% | — | Unchanged |
| 12 | ✓ | Crescent Biopharma INC. | +0.4% | +98.06% | Add |
| 13 | ABVX | Abivax Sa-adr | +0.4% | -8.96% | Trim |
| 14 | GLUE | Monte Rosa Therapeutics INC | +0.3% | -32.23% | Trim |
| 15 | RPTX | Repare Therapeutics INC | +0.2% | — | Unchanged |
| 16 | PVLA | Palvella Therapeutics INC | +0.2% | -24.30% | Trim |
| 17 | AVTX | Avalo Therapeutics INC | +0.1% | +0.00% | Add |
| 18 | PEPG | Pepgen INC | +0.1% | — | Unchanged |
| 19 | ✓ | Engene Holdings INC | +0.1% | — | Unchanged |
| 20 | TENX | Tenax Therapeutics INC | 0% | — | Unchanged |
| 21 | MOLN | Molecular Partners AG -adr | — | — | Unchanged |
| 22 | XFOR | X4 Pharmaceuticals INC | 0% | — | Unchanged |
| 23 | IVA | Inventiva SA - Adr | -0.1% | — | Unchanged |
| 24 | IMA | Imagenebio INC | -0.1% | — | Unchanged |
| 25 | KURA | Kura Oncology INC | -0.1% | — | Unchanged |
| 26 | FHTX | Foghorn Therapeutics INC | -0.1% | — | Unchanged |
| 27 | VTLUSD | Immunic INC | -0.1% | — | Unchanged |
| 28 | TYRA | Tyra Biosciences INC | -0.2% | -41.70% | Trim |
| 29 | TCRX | Tscan Therapeutics INC | -0.2% | — | Unchanged |
| 30 | ACIU | AC Immune SA | -0.2% | — | Unchanged |
| 31 | ELDN | Eledon Pharmaceuticals INC | -0.3% | — | Unchanged |
| 32 | MIRM | Mirum Pharmaceuticals INC | -0.5% | — | Unchanged |
| 33 | FDMT | 4d Molecular Therapeutics In | -0.5% | — | Unchanged |
| 34 | IMCR | Immunocore Holdings Plc-adr | -0.6% | -5.42% | Trim |
| 35 | NKTR | Nektar Therapeutics | -0.7% | +22.17% | Add |
| 36 | GHRS | GH Research PLC | -1.4% | — | Unchanged |
| 37 | SEPN | Septerna INC | -1.5% | -57.15% | Trim |
| 38 | XOMA | Xoma Royalty Corporation | -1.7% | — | Unchanged |
| 39 | AXSM | Axsome Therapeutics INC | -2.1% | -90.60% | Trim |
| 40 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |
| 41 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 42 | IRON | Disc Medicine INC | — | NEW | New buy |
| 43 | IVVD | Invivyd INC | — | NEW | New buy |
| 44 | CELC | Celcuity INC | — | EXIT | Sold out |
| 45 | EPIEUR | Essa Pharma INC | — | EXIT | Sold out |
| 46 | SABS | Sab Biotherapeutics INC | — | EXIT | Sold out |
| 47 | FBRX | Forte Biosciences INC | — | EXIT | Sold out |
| 48 | ✓ | Nls Pharmaceutics LTD | — | EXIT | Sold out |